Skip to content

Clinical trials

Phase 2/3 Substance-Related Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Substance-Related Disorders Phase: Phase 2/3 Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20034
20041
20053
20064
20071
20084
20093
20101
20111
20122
20141
20162
20191
20201
20212
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Terminated2
Unknown status2
Recruiting1
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johns Hopkins University4
King's College London2
University of California, Los Angeles2
University of Oslo2
Virginia Commonwealth University2
Arizona State University1
Boston Children's Hospital1
Coatesville VA Medical Center1
Columbia University1
ContinueYou, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Substance-Related Disorders34
Alcoholism5
Opioid-Related Disorders4
Cocaine-Related Disorders3
Marijuana Abuse3
Conduct Disorder2
Panic Disorder2
Antisocial Personality Disorder1
Anxiety Disorders1
Binge Drinking1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.